COMPANY
Paion Pharma GmbH
Paion Pharma GmbH: marketing authorisation holder, trial sponsor for Angiotensin II, as stated by public registers.
Also written as: PAION PHARMA GMBH.
MARKETING AUTHORISATION HOLDER
Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).
| Angiotensin II | Giapreza (EMEA/H/C/004930), Authorised Regulator EMA |
|---|---|
| Angiotensin II | GIAPREZA 2.5 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION, PLGB 59768/0003, Authorised Regulator MHRA |
TRIAL SPONSOR
Sponsors registered clinical trials of the peptide.
| Angiotensin II | 1 registered trial Trial register EU CTIS |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.